boehringer ingelheim glp-1 ADA: Tolerability questions linger for Boehringer's obesity drug Boehringer Ingelheim strengthens obesity pipeline
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31

























